Valuation
- Market cap
- 49,104,000
- Revenue TTM
- $310,000
- Net income TTM
- $-3,730,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- -1,203.23%
- Debt to equity
- 0.00
Trading
- Volume
- 100
- Avg volume
- 3,562
- Day's range
- $0.48 – $0.48
- Shares out
- 92,649,000
- Stochastic %K
- 64%
- Beta
- 1.48
- Analysts
- Strong Buy
- Price target
- $2.25
Company profile
NetraMark Holdings Inc. provides AI-powered insights and software solutions to trial sponsors, clinical research organizations, and biotechnology companies worldwide. It operates NetraAI platform, an advanced machine learning system purpose-built for analyzing complex clinical trial data to identify meaningful patient subpopulations. The company was formerly known as Nurosene Health Inc. and changed its name to Netra...
Show more
NetraMark Holdings Inc. provides AI-powered insights and software solutions to trial sponsors, clinical research organizations, and biotechnology companies worldwide. It operates NetraAI platform, an advanced machine learning system purpose-built for analyzing complex clinical trial data to identify meaningful patient subpopulations. The company was formerly known as Nurosene Health Inc. and changed its name to NetraMark Holdings Inc. in February 2023. NetraMark Holdings Inc. was founded in 2016 and is headquartered in Toronto, Canada.
- Industry
- Health Information Services
- Sector
- Healthcare
- Phone
- 403 681 2549
- Website
- https://www.netramark.com
- Address
- 1655 Dupont Street, Suite 101, Toronto, Canada
Latest news
No headlines yet.
